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Estrogen and androgen receptors within the liver have been reponed to modulate the 
hepatic regenerati\'e response to partial hepatectomy. Moreover. cyclosporine has 
several untoward effects that might occur as a consequence of alterations in sex hormone 
activity. To evaluate these questions the following experiments were performed. Estrogen 
and androgen receptors in cytosol were quantitated in livers of rats treated with 
cyclosporine or oli"e oil vehicle before and after partial hepatectomy or a sham operation. 
Ornithine decarboxylase activity and thymidine kinase activity "-ere assessed as indices of 
hepatic regeneration. Preoperative lnels of estrogen receptor activity in the hepatic 
cytosol were significantly greater in rats treated with cyclosporine as compared to vehicle 
treated controls (p < 0.01). In contrast. preoperative levels of androgen receptor activity 
in the cyc!osporine-treated and vehicle-treated animals were similar. Following partial 
hepatectomy, a reduction in the actidty of both sex hormone receptors in the hepatic 
cytosol was obser\'ed and was compatible with results described preriously in normal 
animals. Unexpectedly the preoperatil'e levels of ornithine decarboxylase (P < 0.01) and 
thymidine kinase actil'ity (P < 0.01) were significantly greater in the rats treated with 
cyclosporine as compared to the vehicle treated controls. As expected. ornithine decar-
boxylase activity I al 6 hr; and thymidine kinase actil'ity (al 24 hr; rose and peaked in 
response to a partial hepatectomy bllt were significantly greater IP < 0,05) in the rats 
treated lI'iti! cyc/osporine as compared to the vehicle. These results sholl' that cyclospu-
rine treatment causes an increase in the hepatic content of estrogen receptor actil'ity that 
is associated wilh uti enhanced potenlial for a ref,?eneratil'e response, These effects of 
cyclosporille treatment on the sex hormone receptor lel'els ill /il'cr may explain the 
mechanisms responsible for some of the untoward effects of treatment I\'itll this aRetlf, 
KEY WORDS: cyclo'r-.'nne: e~trogen: andmgen: hepatectomy: cytosol. 
The presence and properties of sex hormone recep-
tors in the liver have been studied extensively (1), 
However. the precise function of these receptors 
within the liver is unknown, ~onethelessI in mam-
mals certain functions of the liver are known to 
display a sexual dimorphism (2-4), Testosterone, 
present in utero and after puberty. appears to be the 
major determinant of the differences between the 
sexes in hepatic function. 
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Hepatic regeneration following a partial hepatec-
tomy is associated with a "feminization" of the 
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CYCLOSPORINE AND HORMONE RECEPTORS 
liver in male rats as manifested by an increase in the 
serum level of estradiol and the hepatic activity of 
estrogen receptors. Moreover a reduction in the 
serum level of testosterone and the activity of the 
androgen receptors within the liver occurs (I. 5). 
Translocation of estrogen receptors from the cyto-
sol to th€; nucleus in liver subjected to a prior partial 
hepatectomy coincides with the initiation of DNA 
synthesis. These observations suggest an important 
role for nuclear estrogen and. particularly. an estro-
gen-DNA interaction in the initiation of the regen-
erative process (I. 5). 
In recent years orthotopic transplantation of the 
liver has become accepted as a reasonable treat-
ment for patients with end-stage liver disease (6). 
The criteria currently used in the selection of do-
nors for liver transplantation include ABO blood 
group and size compatibility with the recipient. 
Currently. the sex of the donor is not taken into 
consideration. In view of the sexual dimorphic 
character of hepatic function and the changes in the 
sex hormone status of the liver after transplantation 
(especially if the donor is of the opposite sex). the 
choice of a particular donor sex may be important 
for the initial success of the transplant procedure as 
well as subsequent long-term normal function of the 
graft (7). 
Cyclosporine is the immunosuppressive agent 
most frequently used in organ transplantation. Cur-
rently identified side effects of cyclosporine include 
hepatotoxicity. Leydig cell failure. and increased 
lanugo hair growth (6. 8). The pathogenesis of the 
increased hair growth associated with cyclosporine 
use has not been determined yet. In this study. the 
effect of cyclosporine on the estrogen and androgen 
receptor content of the liver. both before and after 
partial hepatectomy. was determined. The latter 
.:ondition was examined as a model of the regener-
ative response that ol.:curs following liver grafting 
but avoids the confounding effech produced by the 
host's immunologic response to the allograft. 
,tA TERIALS A~a METHODS 
Animals and Chemicals. Adult male inbred Wistar rats 
weighing 250-300 g were purchased from Harlan Spra-
gue-Dawley !Indianapolis. Indiana). Diethyl,tilbestro\. 
nicotinamide adenine dinucleotide. pyridoxal phosphate. 
adenosine triphosphate. unlabeled ornithine. sodium mo-
lybdate. Tris base. calf thymus DNA. and bovine serum 
albumin were purchased from Sigma Chemical Company 
.St. Louis. Missouri). New England Nuclear (Boston. 
\1assachusetts) provided the ['Hlestradiol (99 Ci/mmol). 
[1·Clornithine (57.6 mCi/mmol). 17-alpha-methyl-
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eHlmethyltrienolone ([3H1RI881) (87 Ci/mmol), and un-
labeled R 1881. Tritiated thymidine (5 Ci/mmol) and Aque· 
ous Counting Scintillant were obtained from Amersham 
(Arlington Heights. Illinois). DEAE-cellulose paper was 
purchased from U.S. Industrial Chemicals Company 
(Tuscola. Illinois). All other chemicals were obtained 
from Fisher Scientific Company (Pittsburgh. Pennsylva-
nia). 
Surgical Procedures. Adult male rats were randomly 
allocated to three groups and treated as follows: Group I 
animals received cyclosporine in olive oil (25 mg/kg 
orally) for seven days and an intravenous bolus injection 
of cyclosporine in saline (5 mg/kg) on the eighth day. 
followed immediately by a standard two-thirds partial 
hepatectomy (9). Group II animals received the olive oil 
vehicle orally for seven days and an intravenous injection 
of saline on the eighth day. which was followed immedi-
ately by a standard two-thirds partial hepatectomy. 
Group III animals received cyclosporine according to the 
same treatment schedule as the animals in group I; 
however. they were subjected to a sham operation rather 
than a two-thirds partial hepatectomy on the eighth day. 
All surgical procedures were performed between 9 and 
II AM to eliminate any potential effect of diurnal varia-
tions in the parameters assessed. Light ether anesthesia 
was used for all the surgical procedures and the subse-
quent sacrifice of the animals studied. 
At 6. 24. 48. and 72 hr after partial hepatectomy or 
sham operation. the rats were anesthetized with ether and 
weighed, Blood was withdrawn from their abdominal 
aorta and the remnant liver was removed. weighed. and 
homogenized in four volumes of ice-cold buffer consisting 
of 0.25 M sucrose. 1.5 mM EDT A. 10 mM mercapto-
ethanol. and 10 mM Tris HCI (pH 7.4) using a Brinkman 
Polytron homogenizer. The homogenate was centrifuged 
at \03.000g for I hr at 4° C. and the supernatant obtained 
was used for all the assays performed. 
Estrogen and Androgen Receptors. The specific binding 
of a saturating concentration of [3Hlestradiol was used to 
determine the cytosolic estrogen receptor activity (10). 
The hepatic cytosol was diluted I: I with a buffer consist-
ing of 40 mM sodium molybdate. I.5 mM EDTA. and 10 
mM Tris HCI (pH 7.4) in order to stabilize the estrogen 
receptor. A mixture consisting of 200 ILl diluted cytosol. 
25 ILl 30 ILM ['Hlestradiol and 25 ILl ethanol was used to 
determine total binding of ['Hlestradiol. Nonspecific 
binding was measured in parallel assays in which Eh~ 
ethanol wa, replaced with 25 ILl 3 ILM unlabeled DES 
dissolved in ethanol. In each case. the mixture wa, 
allowed to incubate for 2 hr at 4C C and the reaction was 
terminated by the addition of 0.4 ml I ~ dextran-coated 
charcoal to remove unbound steroid. After centrifuging at 
1500g for 5 min at 4° C. the supernatant was transferred 
carefully to a scintillation vial containing 8 ml ACS 
scintillation fluid. The radioactivity in the supernatant 
was measured in a Packard Tri-Carb 460 CD liquid 
scintillation system (Downers Grove. Illinois). 
The assay used to quantitate the cytosolic androgen 
receptor activity was similar to the one described above 
for the estrogen receptor with minor exceptions (5), Total 
binding was measured using a mixture of 200 ILl of the 
cytosol with 25 ILl tritiated RI881. a synthetic androg~nK 
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Parallel assays in which 25 I ..d unlabeled R 1881 was added 
to the mixture were used to determine nonspecific bind-
ing. The binding of R 1881 to glucocorticoid receptors was 
blocked by adding 5 J.lm triamcinolone acetonide to the 
assay mixture. After an overnight incubation at 4° C. the 
reaction was terminated by adding 0.4 ml 1% dextran-
coated charcoal to remove unbound RI881. The mixture 
was centrifuged at 1500g for 5 min at 4° C and the 
supernatant placed in scintillation vials with 8 ml ACS 
scintillation fluid. The radioactivity present in the super-
natant was counted in a Packard Tri-Carb 460 CD liquid 
scintillation system. 
Thymidine Kinase Activity. The level of thymidine 
kinase activity was determined by measuring the in vitro 
conversion of thymidine to thymidine phosphate (12). 
The reaction mixture consisting of 0.1 ml cytosol, 850 J.lI 
incubation buffer (5 mM adenosine triphosphate and 3.6 
mM magnesium chloride in 50 mM Tris HCI. pH 8.0). and 
50 J.l1 I J.lM eHjthymidine was allowed to incubate for 10 
min at 37° C. The reaction was terminated by immersing 
the assay tubes in boiling water for 2 min. The mixture 
was centrifuged at 1500g for 5 min at 4° C. Aliquots of 0.1 
ml each were removed from each assay tube and spotted 
onto 3.8-cm DEAE-cellulose paper squares. The DEAE-
cellulose paper squares were washed in I mM ammonium 
formate for 5 min. distilled water for 3 min. ammonium 
formate for 5 min. and finally rinsed in distilled water 
again. The squares were placed in glass scintillation vials 
and the radioactivity on the paper eluted into solution by 
the addition of a 0.1 M HCI-0.2 M KCl mixture. After 
allowing 15 min for elution to occur. \0 ml ACS scintil-
lation fluid was added to each vial. The radioactivity 
present in solution was counted in a Packard Tri-Carb 460 
CD liquid scintillation system. 
Miscellaneous Methods. The method of Lowry et al was 
used to determine the cytosolic protein concentration 
using bovine serum albumin as the standard (3). Serum 
measures of liver injury were assessed using a Random 
Access Chemistry Anal:. zer (Technicon RA 500). 
All results are reponed as mean values::: SEM. Statis-
tical analysis of the data \I. as performed using a Student's 
t test. A P value of 0.05 or less was considered to 
represent a significant dIfference. 
RESULTS 
The pattern of liver injury observed in the ani-
mals studied is sho\\ n in Table I. Note that the 
measure of liver injury assessed was similar in all 
groups prior to surgery. A significant increase in 
AST levels occurred with the hepatic injury of 
partial hepatectomy (groups I and Il). A smaller but 
nonetheless significant increase in AST levels was 
present also in the sham-operated animals (group 
Ill). Interestingly. the degree of hepatic injury. 
measured by the serum AST level. was less in the 
rats pretreated with cyclosporine (group I) than it 
was in the vehicle-treated animals (group II) follow-
ing partial hepatectomy. 
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TABLE I. SERUI ,\LA!"I!"E AMf~lqoA!"pcboApb (AST") LEVELS 
AFTER CYCLOSPORI!"E qobAqMb~q .... !"D PARTIAL HEPATECTOMY 
(GROLP II. VEHICLE TREATME!"T ,"'SO PARTIAL HEPATECTOMY 
(GROLP 11). ,"'SO CYCLOSPORI!"E TREATME!"T A!"D SHAM 
OPERATlO!" (GROLP III) 
AST (1UIliter) 
Time (hr) Group I Group II Group III 
0 113 :!: 18 85 :!: 8 83 :!: 18 
6 15:!0 :!: 407 1146:±: 167 147:!: 15 
24 1399 :±: 78 :!467 :!: 663 110 :!: 2 
48 543 :±: 100 1976:±: 800 106 :!: 8 
72 439 :±: 178 NA 75 :!: 2 
• Alanine aminotran sferase, 
tMean ::: spot. ;\" = 4-8 animals per time per group, 
The effects of pretreatment with cyclosporine and 
subsequent partial hepatectomy on the cytosolic 
estrogen receptor activity of liver are shown in 
Table 2. Preoperative levels of estrogen receptor 
activity were significantly greater (P < 0.01) in the 
rats treated v,'ith cyclosporine (groups I and III) 
than in the olive oil-treated control group (group 11). 
A significant decrease in estrogen receptor activity 
was evident 6 hr after operation in all three groups 
(Table 2). A further decrease in the hepatic estrogen 
receptor activity occurred between 6 and 72 hr in 
the cyclosporine-treated animals subjected to the 
sham operation such that the levels at 72 hr were 
approximately half those measured preoperatively 
in the same group. It should be noted. however. 
that the estrogen receptor activity at this point. in 
this group of animals (group Ill). was still greater (P 
< 0.05) than the preoperative level present in the 
vehicle (olive oil) -treated animals (group II) , The 
cyc1osporine-treated rats subjected to partial hepa-
tectom! (group I) experienced a further reduction 
(P < 0,01) in the estrogen receptor activity present 
in the Ii \er at 24 hr after partial hepatectomy. with 
the level achieved being approximately one fourth 
of the preoperative level. Thereafter the estrogen 
receptor activity increased steadily and returned 
T.",BLE ~I LEVELS OF ESTROGE'o; RECEPTOR ACTI\ITY ,-.; 
GROlPS 1-111* 
Estrogen receptor acril'itY Ijmn/'mR protein) 
Time Ihrl Group I Group 1/ Group III 
0 43 :±: 4 18 :!: I 43 ::: 4 
6 30 :!: 4 9:!: 0,3 34 ::: 0,6 
~4 10 :!: 2 II ~ ~ 34 :!: 4 
48 26 :!: 3 14 :!: 3 24 ::: I 
n 34 :!: 5 23 :!: 2 23 :!: 2 
"Mean := SEM . .\" = 4-8 animals per group per time point. 
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TABLE 3. LEVELS OF A"DROGE'" RECEPTOR ACTIVITY IN 
GR0lPS I-Ill" 
Androgen rneptor aeti\'iry (jmo/lmg protein) 
Time (hr) Group I Group II Group III 
0 \.87 ::: 0.56 \.99 = 0.49 1.87 ::: 0.56 
6 0.62::: 0.25 0.58 = 0.19 1.02 = 0.27 
:4 2.69::: 0.60 1.05 = 0.35 0.53 = 0.2 
48 3.35::: 0.40 2.0 = 0.76 0.56::: 0.28 
. .., \,42 ::: 0.19 NA \.61 = 0.15 
"Mean::: SEM. N = 4-8 animals per group per time period. 
almost to the preoperative level by 72 hr following 
partial hepatectomy. The estrogen receptor re-
sponse of the vehicle-treated controls subjected to a 
partial hepatectomy (group II) was qualitatively 
similar to that of the cyclosporine-treated animals 
IgrOUp l) but occurred at a much reduced initial 
level of activity and subsequent percent change 
\I, ith time after the partial hepatectomy (Table 2). 
The effects of cyclosporine and subsequent par-
tial hepatectomy on the hepatic cytosolic androgen 
receptor activity are shown in Table 3. The preoper-
ative levels of androgen receptor activity in the 
.:yclosporine-treated and vehicle-treated animals 
were similar. A reduction in androgen receptor 
activity occurred at 6 hr after both partial hepatec-
:omy and sham operation with the decline being 
similar in all three groups (Table 3). The reduction 
In androgen receptor activity persisted for 48 hr in 
:he sham-operated animals. whereas in both the 
\ ehicle-treated partially hepatectomized animals 
and the cyclosporine-treated partially hepatecto-
l1ized animals. the receptor activity either in-
.:reased to (group II) or surpassed (group I) the 
~reoperative level at ~U hr. The hepatic androgen 
~K:K:cptor activity at O~ and 48 hr \'-as greater (P < 
':' l~f in rats treated \'-ith cyclosporine and partial 
' . .:ratectomy (group I I than in either of the other 
~DDDDM groups. 
The changes in ornithine decart:>oxyla'>e activity 
c''-"cned after partial hepatectom~ and sham oper-
,,:ion in cyclosporine- and vehicle-treated animals 
are shown in Table 4. The preoperative levels of 
L,mithine decarboxylase activity were greater in the 
livers of cyclosporine-treated rats (groups I and III) 
than those in the vehicle-treated animals (Group II) 
IP < 0.01). A significant increase in the hepatic 
activity of ornithine decarboxylase activity oc-
.:urred postoperatively and peaked at 6 hr in all 
:hree groups compared to the respective preopera-
tive control levels <P < 0.01). The peak level of 
0mithine decarboxylase activity was greatest in the 
TABLE 4. LEVELS OF lo~fqefpb DECARBOXYL. .. SE ACTIVITY I!'I 
GROUPS I-Ill' 
Time (hr) 
0 
6 
24 
48 
72 
Ornithine decarboxylase aetidty 
(epmlmg protein) 
Group I Group II Group III 
726 = 18 546 :t 11 726:t 18 
4984 = 337 3096 = 785 2573 :to 238 
3619 :to 631 2068 ::: 711 685 = 18 
2319 = ~"*~ 2557 = 128 741 = 28 
1322::: ~ 1142 ::: 259 664= 10 
*Mean :t SEM. N = 4-8 animals per group per time period. 
rats treated with cyclosporine and subjected to a 
partial hepatectomy (Table 4). Ornithine decarbox-
ylase activity returned toward preoperative levels 
at 24 hr in all three groups of rats studied but 
remained elevated (p < 0.05) compared to preoper-
ative control levels in both groups subjected to a 
partial hepatectomy: again the ornithine decarbox-
ylase activity was greatest in the rats treated with 
cyclosporine (group 1). 
As was the case with ornithine decarboxylase. 
the basal preoperative levels of thymidine kinase 
activity (Table 5) \'- ere significantly greater in rats 
pretreated with cyclosporine (groups I and Ill) than 
in the vehicle-treated animals (P < 0.01). The 
thymidine kinase activity in the liver of cyclospo-
rine-treated rats subjected to sham operation (group 
Ill) was significantly less at 24 hr than it was 
preoperatively (P < 0.05). Thereafter a delayed and 
rather minor increase in thymidine kinase activity 
occurred at 48 and -:-2 hr after sham operation with 
the level present at 72 hr being greater than the 
preoperative basal level (p < 0.05) (Table 5). In 
contrast. a significant increase in thymidine kinase 
activity was observed at 24 hr after partial hepatec-
tomy (groups I and II ,. with levels being greater (p 
< 0.05) in the rab pretreated with c: closporine 
(group I) as compared to the vehicle treated con-
trols. The increa~eg \evels of thymiJine kina~e 
activity seen after rartial hepatcctom~ persi~teg 
T.\BLE S. LEVELS or THY\IIIlI';(, KI'i·\SI :\cTI\If) I'" 
GR()l PS I-III' 
ThymiJlr, /"'ill<1.\(· <1eri.flr rJpm ff/~ proteill) 
Time Ihr) Group I Group II Group III 
0 4364 = ~- 1346 !: ~19 ·1364 !: 847 
6 4403= 1~4~ 581 !: 90 1R~R = 101 
:!4 16777 !: 5>< I IIIIO!: 1169 I09H !: 7f1 
48 10736 = 64(J 1~S~P !: 1457 t~f !: 749 
72 14794 = 41~ IlnO !: 459 R4~: = 43f1 
'Mean = SEM. :v ~ 4-8 a:limals per group per lim.: period. 
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throughout the duration of the study with the levels 
being greater (P < 0.05) always in the rats pre-
treated with cyclosporine (group I) as compared to 
the animals receiving the olive oil vehicle. 
DISCUSSION 
The important results of this study are that the 
preoperative levels of estrogen receptors present in 
the liver of animals treated with cyclosporine are 
greater than they are in rats receiving the olive oil 
vehicle. In contrast to the changes observed for the 
activity of estrogen receptors, the androgen recep-
tor activity in hepatic cytosol was not affected by 
cyclosporine treatment. The changes in both the 
estrogen and the androgen receptor activity content 
of the liver after partial hepatectomy in the vehicJe-
treated animals were similar to those described 
previously for normal animals (l, 5, 14). Similar 
qualitative changes were seen after partial hepatec-
tomy in the cyclosporine-treated rats. However, the 
quantitative changes were greater for both the es-
trogen and the androgen receptor. Moreover the 
potential for a regenerative response to a hepatic 
injury determined by measuring ornithine decar-
boxylase activity and thymidine kinase activity was 
greater in the animals treated with cyclosporine 
(group I) than it was in the vehicle-treated controls 
(group 11). 
Certain liver functions have been noted to display 
sexual dimorphism in mammals (2-4). Some of 
these functions may be critical for a completely 
successful outcome following liver transplantation. 
Because cyclosporine is used routinely after liver 
transplantation and because it is known to affect 
hair growth and Leydig cell function, and the sex 
hormone status of the liver is modified in response 
to or as part of the regenerative response, it would 
appear to be important to investigate the effect of 
cyclosporine on the sex hormone receptor status of 
the liver both before and after a surgical procedure 
associated with a hepatic regenerative response. 
Thus, in this study, both the estrogen receptor and 
androgen receptor activity in the hepatic cytosol 
was studied in response to prior cyclosporine treat-
ment and to a regenerative stimulus, a two-thirds 
partial hepatectomy. It is of considerable interest 
that the estrogen receptor but not the androgen 
receptor activity of the liver is modified by cyclo-
sporine therapy. Although no qualitative differ-
ences in the estrogen receptor and androgen recep-
tor changes associated with hepatic regeneration 
to 
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occurring after a two-thirds partial hepatectomy 
were observed, significant quantitative changes in 
these two functions in the liver between treatment 
groups was evident. These changes are particularly 
interesting when the measures of hepatic injury 
determined after partial hepatectomy in the two 
groups of animals subjected to this operative injury 
are examined. Specifically the injury in the cyclos-
porine-treated animals was significantly less than 
that seen in the vehicle-treated controls. 
During liver transplantation, the graft liver can be 
injured in a number of different ways, including an 
ischemic injury related to procurement and preser-
vation, an immunological injury as a result of the 
attack mounted by the recipient's immune response 
to the graft, an infectious attack, and finally. injury 
occurring as a result of the toxicity of certain drugs, 
particularly cyclosporine, used following transplan-
tation. Occasionally, because of a mismatch be-
tween the size of the donor and the recipient, a 
small liver is transplanted into a larger recipient and 
hepatic regeneration of the liver graft is required to 
meet the metabolic needs of the recipient (15, 16). 
Similarly. because of the lack of suitable pediatric 
donors, some centers use partially hepatectomized 
adult livers in pediatric recipients (17). Both of 
these situations necessitate a regenerative response 
in the transplanted liver (15, 16). Moreover, a 
normal regenerative response in these particular 
situations may be crucial for the ultimate success of 
the liver transplant procedure. 
Previous studies have shown a temporal relation-
ship between the transfer of cytosolic estrogen 
receptor to the nuclear compartment and the onset 
of DNA synthesis in regenerating liver (1"*, 18). 
These observations have implicated estrogens and 
their receptors as playing an important w\e in the 
process of hepatic regeneration. Relevant to these 
findings are the results reported herein ..... hi.::h dem-
onstrate a greater level of estrogen receptor activity 
in the hepatic cytosol of rats treated with .:: ~ c1o~po­
nne. 
Estrogens have been implicated as playing a 
crucial role in the pathogenesis of a number of 
pathological states of the liver (19-24). Of particular 
interest in this regard is the role that estrogens and 
their receptors appear to play in the pathogenesis of 
hepatic neoplasia (19,20). Livers containing hepatic 
adenoma and focal nodular hyperplasia have been 
shown to have an increased estrogen receptor con-
tent (25). The data presented here demonstrate that 
the livers of cyclosporine-treated rats also have an 
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increased estrogen receptor activity. This finding 
may have important implications. As the number of 
liver transplants performed increases and as sur-
vival rates improve, the number of long-term survi-
vors after liver transplantation will increase. The 
possible effect of an increased estrogen receptor 
activity in the livers of these cyclosporine-treated 
survivors is currently unknown. 
It is of some interest that previous studies have 
shown that prolactin plays an important role in the 
regulation of the cytosolic content of estrogen re-
ceptors in liver (27). Specifically, the decrease in 
hepatic cytosolic estrogen receptor content seen 
after hypophysectomy can be restored partially by 
the administration of exogenous prolactin (26). Re-
cently it has been shown that the administration of 
cyclosporine to rats causes an increase in their 
prolactin levels (27). Thus. the increase in prolactin 
levels associated with cyclosporine may be respon-
sible. at least in part. for the enhanced activity of 
the estrogen receptor observed in this study. 
Regardless of the specific mechanism involved. 
the results of the present studies demonstrate that 
treatment with cyclosporine results in an increase in 
hepatic content of estrogen receptor activity within 
the liver and that this is associated with an increase 
in activity within the liver of thymidine kinase and 
orthinithine decarboxylase. It is interesting to spec-
ulate also that the changes observed in the hepatic 
content of estrogen and androgen receptor levels in 
the cyclosporine-treated animals studied. if also 
present in other tissues. may explain. at least in 
part. some of the untoward consequences of cyclo-
sporine treatment observed clinically. 
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